Risk analysis of analytical validations by probabilistic modification of FMEA

Publication: Research - peer-reviewJournal article – Annual report year: 2012

Standard

Risk analysis of analytical validations by probabilistic modification of FMEA. / Barends, D.M.; Oldenhof, M.T.; Vredenbregt, M.J.; Nauta, Maarten .

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 64-65, 2012, p. 82-86.

Publication: Research - peer-reviewJournal article – Annual report year: 2012

Harvard

APA

CBE

MLA

Vancouver

Author

Barends, D.M.; Oldenhof, M.T.; Vredenbregt, M.J.; Nauta, Maarten / Risk analysis of analytical validations by probabilistic modification of FMEA.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 64-65, 2012, p. 82-86.

Publication: Research - peer-reviewJournal article – Annual report year: 2012

Bibtex

@article{f0bdec193a124304b76d1efc8ed255cd,
title = "Risk analysis of analytical validations by probabilistic modification of FMEA",
keywords = "Analytical validation, FMEA, Human factor, Risk analysis, NIR",
publisher = "Elsevier BV",
author = "D.M. Barends and M.T. Oldenhof and M.J. Vredenbregt and Maarten Nauta",
year = "2012",
doi = "10.1016/j.jpba.2012.02.009",
volume = "64-65",
pages = "82--86",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",

}

RIS

TY - JOUR

T1 - Risk analysis of analytical validations by probabilistic modification of FMEA

A1 - Barends,D.M.

A1 - Oldenhof,M.T.

A1 - Vredenbregt,M.J.

A1 - Nauta,Maarten

AU - Barends,D.M.

AU - Oldenhof,M.T.

AU - Vredenbregt,M.J.

AU - Nauta,Maarten

PB - Elsevier BV

PY - 2012

Y1 - 2012

N2 - Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.

AB - Risk analysis is a valuable addition to validation of an analytical chemistry process, enabling not only detecting technical risks, but also risks related to human failures. Failure Mode and Effect Analysis (FMEA) can be applied, using a categorical risk scoring of the occurrence, detection and severity of failure modes, and calculating the Risk Priority Number (RPN) to select failure modes for correction. We propose a probabilistic modification of FMEA, replacing the categorical scoring of occurrence and detection by their estimated relative frequency and maintaining the categorical scoring of severity. In an example, the results of traditional FMEA of a Near Infrared (NIR) analytical procedure used for the screening of suspected counterfeited tablets are re-interpretated by this probabilistic modification of FMEA. Using this probabilistic modification of FMEA, the frequency of occurrence of undetected failure mode(s) can be estimated quantitatively, for each individual failure mode, for a set of failure modes, and the full analytical procedure.

KW - Analytical validation

KW - FMEA

KW - Human factor

KW - Risk analysis

KW - NIR

U2 - 10.1016/j.jpba.2012.02.009

DO - 10.1016/j.jpba.2012.02.009

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

VL - 64-65

SP - 82

EP - 86

ER -